newsfilter
← Latest News
GlobeNewswire·

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

- On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with First Participant Dosed and Others in Screening - - Initial Clinical Data from Gene Therapy Trial for Hunter Syndrome